EPISODE · Dec 9, 2020 · 28 MIN
GU Podcast (2020): Genetic Testing And Personalized Medicine In Prostate Cancer
from AUAUniversity · host American Urological Association
At the conclusion of this activity, participants will be able to: 1. Identify the role of genetic testing in men with advanced, metastatic and CRPC. 2. State the criteria for genetic testing of prostate cancer patients, the gene panels available, and options for testing these men. 3. Describe results of genetic testing and relay this information to patients in order to facilitate shared-decision making based on the test results. 4. Explain the importance of testing for germline mutations and their implication for novel therapies such as PARP inhibitors. This educational series is supported by independent educational grants from: Astellas AstraZeneca Bristol Myers Squibb Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc Sanofi Genzyme UroGen Pharma, Inc.
What this episode covers
At the conclusion of this activity, participants will be able to: 1. Identify the role of genetic testing in men with advanced, metastatic and CRPC. 2. State the criteria for genetic testing of prostate cancer patients, the gene panels available, and options for testing these men. 3. Describe results of genetic testing and relay this information to patients in order to facilitate shared-decision making based on the test results. 4. Explain the importance of testing for germline mutations and their implication for novel therapies such as PARP inhibitors. This educational series is supported by independent educational grants from: Astellas AstraZeneca Bristol Myers Squibb Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc Sanofi Genzyme UroGen Pharma, Inc.
NOW PLAYING
GU Podcast (2020): Genetic Testing And Personalized Medicine In Prostate Cancer
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.